Reuters Health: Study examines psychotherapy's role in intervention for BPD
UC expert says more detailed study needed to support conclusions
A recent randomized trial in Australia showed that young people can be effectively treated for borderline personality disorder with or without individual psychotherapy.
In an article about the study, Reuters Health interviewed Maria Espinola, PsyD, assistant professor in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati College of Medicine, about her thoughts on the study.
"Although the results look promising, I don't fully agree with the conclusions," Espinola told Reuters Health. "First, the authors failed to include the participants and the providers' race and ethnicity.
"Second, it appears that the authors assessed suicidal ideation using the Beck Scale for Suicide Ideation, but could have used additional assessment tools to better determine suicide risk," she continued.
Read the Reuters Health article.
Featured image of Maria Espinola, PsyD, taken by Colleen Kelley/UC Creative + Brand.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.